Parievsky A[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2012	1
2015	1
2017	1
2025	0

Page 1

Evidence from the R6/2 Mouse Model of Huntington's Disease for Using Abnormal Brain Metabolism as a Biomarker for Evaluating Therapeutic Approaches for Treatment.

Parievsky A, Cepeda C, Levine MS. Parievsky A, et al. Future Neurol. 2012;7(5):527-530. doi: 10.2217/fnl.12.51. Future Neurol. 2012. PMID: 25892970 Free PMC article.

Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.

Parievsky A, Moore C, Kamdjou T, Cepeda C, Meshul CK, Levine MS. Parievsky A, et al. Neurobiol Dis. 2017 Dec;108:29-44. doi: 10.1016/j.nbd.2017.07.020. Epub 2017 Jul 27. Neurobiol Dis. 2017. PMID: 28757327 Free PMC article.

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease.

Holley SM, Joshi PR, Parievsky A, Galvan L, Chen JY, Fisher YE, Huynh MN, Cepeda C, Levine MS. Holley SM, et al. Among authors: parievsky a. eNeuro. 2015 Jan-Feb;2(1):ENEURO.0008-14.2015. doi: 10.1523/ENEURO.0008-14.2015. eNeuro. 2015. PMID: 26203463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year